Nobelpharma America, LLC is focused on the commercialization of pharmaceuticals and medical devices that expand treatment options for people with rare diseases. Nobelpharma America was established in 2019 as the first wholly owned global subsidiary of Nobelpharma Co., Ltd., based in Tokyo Japan. In 2022, Nobelpharma America’s first product received FDA approval and launched in the U.S. Please visit our booth for more information.